Subtyping prostate cancer to predict response to hormone therapy Grant US-11873532-B2 United States of America 16 Jan 2024
Use of genomic signatures to predict responsiveness of patients with prostate cancer to… Grant US-11414708-B2 United States of America 16 Aug 2022
USE OF IMMUNE CELL-SPECIFIC GENE EXPRESSION FOR PROGNOSIS OF PROSTATE CANCER AND… Application EP-3662082-A4 European Patent Office 18 Aug 2021